$GHDX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in GENOMIC HEALTH INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in GENOMIC HEALTH INC. Get notifications about new insider transactions in GENOMIC HEALTH INC for free.
Page: < prev 1 2 3 4 5 6 7 ... 28 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 11 2019 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Buy | M | 33.21 | 1,500 | 49,815 | 20,917 | 19.4 K to 20.9 K (+7.73 %) |
| Sep 11 2019 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Buy | M | 31.12 | 3,000 | 93,360 | 19,417 | 16.4 K to 19.4 K (+18.27 %) |
| Aug 30 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Gift | G | 0.00 | 95,289 | 0 | 0 | 95.3 K to 0 (-100.00 %) |
| Aug 30 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Gift | G | 0.00 | 95,289 | 0 | 0 | 95.3 K to 0 (-100.00 %) |
| Aug 30 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Buy | J | 0.00 | 8,341 | 0 | 95,289 | 86.9 K to 95.3 K (+9.59 %) |
| Aug 30 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Buy | J | 0.00 | 8,340 | 0 | 95,289 | 86.9 K to 95.3 K (+9.59 %) |
| Aug 30 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | J | 0.00 | 8,866 | 0 | 43,361 | 52.2 K to 43.4 K (-16.98 %) |
| Aug 30 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | J | 0.00 | 7,815 | 0 | 165,610 | 173.4 K to 165.6 K (-4.51 %) |
| Aug 19 2019 | GHDX | GENOMIC HEALTH INC | Radford Jason W. | Chief Legal Officer | Sell | S | 74.80 | 100 | 7,480 | 29,295 | 29.4 K to 29.3 K (-0.34 %) |
| Aug 19 2019 | GHDX | GENOMIC HEALTH INC | Radford Jason W. | Chief Legal Officer | Sell | S | 74.09 | 2,081 | 154,189 | 29,395 | 31.5 K to 29.4 K (-6.61 %) |
| Aug 12 2019 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Option Exercise | M | 29.34 | 25,000 | 733,500 | 40,000 | |
| Aug 12 2019 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Option Exercise | M | 29.34 | 25,000 | 733,500 | 65,000 | |
| Aug 12 2019 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Sell | S | 74.37 | 1,000 | 74,369 | 108,468 | 109.5 K to 108.5 K (-0.91 %) |
| Aug 12 2019 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Sell | S | 73.63 | 24,000 | 1,767,173 | 109,468 | 133.5 K to 109.5 K (-17.98 %) |
| Aug 12 2019 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Buy | M | 29.34 | 25,000 | 733,500 | 133,468 | 108.5 K to 133.5 K (+23.05 %) |
| Aug 12 2019 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Sell | S | 74.23 | 9,235 | 685,470 | 108,468 | 117.7 K to 108.5 K (-7.85 %) |
| Aug 12 2019 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Sell | S | 73.63 | 15,765 | 1,160,796 | 117,703 | 133.5 K to 117.7 K (-11.81 %) |
| Aug 12 2019 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Buy | M | 29.34 | 25,000 | 733,500 | 133,468 | 108.5 K to 133.5 K (+23.05 %) |
| Aug 12 2019 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Gift | G | 0.00 | 800 | 0 | 108,152 | 109 K to 108.2 K (-0.73 %) |
| Aug 12 2019 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Option Exercise | M | 31.12 | 3,000 | 93,360 | 3,000 | |
| Aug 12 2019 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Option Exercise | M | 33.21 | 1,103 | 36,631 | 45,707 | |
| Aug 12 2019 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Option Exercise | M | 31.12 | 397 | 12,355 | 6,000 | |
| Aug 12 2019 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Sell | S | 74.21 | 1,277 | 94,770 | 16,417 | 17.7 K to 16.4 K (-7.22 %) |
| Aug 12 2019 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Sell | S | 73.56 | 1,723 | 126,748 | 17,694 | 19.4 K to 17.7 K (-8.87 %) |
| Aug 12 2019 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Sell | S | 74.20 | 403 | 29,903 | 19,417 | 19.8 K to 19.4 K (-2.03 %) |
| Aug 12 2019 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Sell | S | 73.57 | 700 | 51,502 | 19,820 | 20.5 K to 19.8 K (-3.41 %) |
| Aug 12 2019 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Sell | S | 72.80 | 397 | 28,902 | 20,520 | 20.9 K to 20.5 K (-1.90 %) |
| Aug 12 2019 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Buy | M | 31.12 | 3,000 | 93,360 | 20,917 | 17.9 K to 20.9 K (+16.74 %) |
| Aug 12 2019 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Buy | M | 33.21 | 1,103 | 36,631 | 17,917 | 16.8 K to 17.9 K (+6.56 %) |
| Aug 12 2019 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Buy | M | 31.12 | 397 | 12,355 | 16,814 | 16.4 K to 16.8 K (+2.42 %) |
| Aug 07 2019 | GHDX | GENOMIC HEALTH INC | McEachron Kim | Chief People Office ... | Option Exercise | M | 28.05 | 2,438 | 68,386 | 6,562 | |
| Aug 07 2019 | GHDX | GENOMIC HEALTH INC | McEachron Kim | Chief People Office ... | Option Exercise | M | 30.69 | 9,665 | 296,619 | 0 | |
| Aug 07 2019 | GHDX | GENOMIC HEALTH INC | McEachron Kim | Chief People Office ... | Sell | S | 71.53 | 12,103 | 865,723 | 36,472 | 48.6 K to 36.5 K (-24.92 %) |
| Aug 07 2019 | GHDX | GENOMIC HEALTH INC | McEachron Kim | Chief People Office ... | Buy | M | 28.05 | 2,438 | 68,386 | 48,575 | 46.1 K to 48.6 K (+5.28 %) |
| Aug 07 2019 | GHDX | GENOMIC HEALTH INC | McEachron Kim | Chief People Office ... | Buy | M | 30.69 | 9,665 | 296,619 | 46,137 | 36.5 K to 46.1 K (+26.50 %) |
| Aug 07 2019 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Sell | S | 72.86 | 8,140 | 593,088 | 83,795 | 91.9 K to 83.8 K (-8.85 %) |
| Aug 07 2019 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Sell | S | 72.14 | 16,860 | 1,216,243 | 91,935 | 108.8 K to 91.9 K (-15.50 %) |
| Aug 07 2019 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Sell | S | 71.85 | 2,471 | 177,544 | 108,795 | 111.3 K to 108.8 K (-2.22 %) |
| Aug 07 2019 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Sell | S | 71.22 | 22,529 | 1,604,585 | 111,266 | 133.8 K to 111.3 K (-16.84 %) |
| Aug 05 2019 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Sell | S | 72.43 | 25,000 | 1,810,858 | 133,795 | 158.8 K to 133.8 K (-15.74 %) |
| Aug 05 2019 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Sell | S | 73.22 | 7,372 | 539,807 | 158,795 | 166.2 K to 158.8 K (-4.44 %) |
| Aug 05 2019 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Sell | S | 72.72 | 17,628 | 1,281,977 | 166,167 | 183.8 K to 166.2 K (-9.59 %) |
| Jul 11 2019 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | CFO | Option Exercise | M | 17.18 | 6,471 | 111,172 | 0 | |
| Jul 11 2019 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | CFO | Sell | S | 57.33 | 5,033 | 288,527 | 43,970 | 49 K to 44 K (-10.27 %) |
| Jul 11 2019 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | CFO | Sell | S | 56.23 | 1,438 | 80,859 | 49,003 | 50.4 K to 49 K (-2.85 %) |
| Jul 11 2019 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | CFO | Buy | M | 17.18 | 6,471 | 111,172 | 50,441 | 44 K to 50.4 K (+14.72 %) |
| Jul 10 2019 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Sell | S | 57.06 | 7,800 | 445,034 | 183,795 | 191.6 K to 183.8 K (-4.07 %) |
| Jul 10 2019 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Sell | S | 56.27 | 17,200 | 967,909 | 191,595 | 208.8 K to 191.6 K (-8.24 %) |
| Jul 10 2019 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Sell | S | 57.76 | 4,048 | 233,814 | 208,795 | 212.8 K to 208.8 K (-1.90 %) |
| Jul 10 2019 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Sell | S | 56.97 | 20,952 | 1,193,570 | 212,843 | 233.8 K to 212.8 K (-8.96 %) |
| Jul 10 2019 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Sell | S | 57.06 | 7,800 | 445,034 | 183,795 | 191.6 K to 183.8 K (-4.07 %) |
| Jul 10 2019 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Sell | S | 56.27 | 17,200 | 967,909 | 191,595 | 208.8 K to 191.6 K (-8.24 %) |
| Jul 10 2019 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Sell | S | 57.76 | 4,048 | 233,814 | 208,795 | 212.8 K to 208.8 K (-1.90 %) |
| Jul 10 2019 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Sell | S | 56.97 | 20,952 | 1,193,570 | 212,843 | 233.8 K to 212.8 K (-8.96 %) |
| Jul 09 2019 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Option Exercise | M | 31.12 | 3,000 | 93,360 | 6,397 | |
| Jul 09 2019 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Option Exercise | M | 31.12 | 1,500 | 46,680 | 9,397 | |
| Jul 09 2019 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Sell | S | 57.74 | 200 | 11,548 | 16,417 | 16.6 K to 16.4 K (-1.20 %) |
| Jul 09 2019 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Sell | S | 56.95 | 1,300 | 74,030 | 16,617 | 17.9 K to 16.6 K (-7.26 %) |
| Jul 09 2019 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Sell | S | 57.85 | 501 | 28,985 | 17,917 | 18.4 K to 17.9 K (-2.72 %) |
| Jul 09 2019 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Sell | S | 56.95 | 2,499 | 142,324 | 18,418 | 20.9 K to 18.4 K (-11.95 %) |
| Jul 09 2019 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Buy | M | 31.12 | 1,500 | 46,680 | 20,917 | 19.4 K to 20.9 K (+7.73 %) |
| Jul 09 2019 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Buy | M | 31.12 | 3,000 | 93,360 | 19,417 | 16.4 K to 19.4 K (+18.27 %) |
| Jul 09 2019 | GHDX | GENOMIC HEALTH INC | McEachron Kim | Chief People Office ... | Option Exercise | M | 30.69 | 5,335 | 163,731 | 9,665 | |
| Jul 09 2019 | GHDX | GENOMIC HEALTH INC | McEachron Kim | Chief People Office ... | Sell | S | 60.01 | 5,335 | 320,151 | 36,472 | 41.8 K to 36.5 K (-12.76 %) |
| Jul 09 2019 | GHDX | GENOMIC HEALTH INC | McEachron Kim | Chief People Office ... | Buy | M | 30.69 | 5,335 | 163,731 | 41,807 | 36.5 K to 41.8 K (+14.63 %) |
| Jul 03 2019 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Grant | A | 58.86 | 212 | 12,478 | 68,935 | 68.7 K to 68.9 K (+0.31 %) |
| Jul 03 2019 | GHDX | GENOMIC HEALTH INC | Flannelly Barry P | Director | Grant | A | 58.86 | 212 | 12,478 | 212 | 0 to 212 |
| Jul 03 2019 | GHDX | GENOMIC HEALTH INC | FUCHS HENRY J | Director | Grant | A | 58.86 | 212 | 12,478 | 7,648 | 7.4 K to 7.6 K (+2.85 %) |
| Jul 03 2019 | GHDX | GENOMIC HEALTH INC | GRAHAM GINGER L | Director | Grant | A | 58.86 | 212 | 12,478 | 53,119 | 52.9 K to 53.1 K (+0.40 %) |
| Jul 03 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Grant | A | 58.86 | 424 | 24,957 | 7,641,672 | 7.6 M to 7.6 M (+0.01 %) |
| Jul 03 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Grant | A | 58.86 | 424 | 24,957 | 1,216,909 | 1.2 M to 1.2 M (+0.03 %) |
| Jul 03 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Grant | A | 58.86 | 424 | 24,957 | 244,225 | 243.8 K to 244.2 K (+0.17 %) |
| Jul 03 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Grant | A | 58.86 | 424 | 24,957 | 159,853 | 159.4 K to 159.9 K (+0.27 %) |
| Jul 03 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Grant | A | 58.86 | 424 | 24,957 | 52,227 | 51.8 K to 52.2 K (+0.82 %) |
| Jul 03 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Grant | A | 58.86 | 424 | 24,957 | 173,425 | 173 K to 173.4 K (+0.25 %) |
| Jun 18 2019 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Option Exercise | A | 52.41 | 6,583 | 345,015 | 6,583 | |
| Jun 18 2019 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Grant | A | 0.00 | 955 | 0 | 68,723 | 67.8 K to 68.7 K (+1.41 %) |
| Jun 18 2019 | GHDX | GENOMIC HEALTH INC | FUCHS HENRY J | Director | Option Exercise | A | 52.41 | 6,583 | 345,015 | 6,583 | |
| Jun 18 2019 | GHDX | GENOMIC HEALTH INC | FUCHS HENRY J | Director | Grant | A | 0.00 | 955 | 0 | 7,436 | 6.5 K to 7.4 K (+14.74 %) |
| Jun 18 2019 | GHDX | GENOMIC HEALTH INC | GRAHAM GINGER L | Director | Option Exercise | A | 52.41 | 6,583 | 345,015 | 6,583 | |
| Jun 18 2019 | GHDX | GENOMIC HEALTH INC | GRAHAM GINGER L | Director | Grant | A | 0.00 | 955 | 0 | 52,907 | 52 K to 52.9 K (+1.84 %) |
| Jun 18 2019 | GHDX | GENOMIC HEALTH INC | Parker Geoffrey M. | Director | Option Exercise | A | 52.41 | 6,583 | 345,015 | 6,583 | |
| Jun 18 2019 | GHDX | GENOMIC HEALTH INC | Parker Geoffrey M. | Director | Grant | A | 0.00 | 955 | 0 | 955 | 0 to 955 |
| Jun 18 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Option Exercise | A | 52.41 | 13,166 | 690,030 | 13,166 | |
| Jun 18 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Grant | A | 0.00 | 1,910 | 0 | 7,641,248 | 7.6 M to 7.6 M (+0.03 %) |
| Jun 18 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Grant | A | 0.00 | 1,910 | 0 | 1,216,485 | 1.2 M to 1.2 M (+0.16 %) |
| Jun 18 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Grant | A | 0.00 | 1,910 | 0 | 243,801 | 241.9 K to 243.8 K (+0.79 %) |
| Jun 18 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Grant | A | 0.00 | 1,910 | 0 | 159,429 | 157.5 K to 159.4 K (+1.21 %) |
| Jun 18 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Grant | A | 0.00 | 1,910 | 0 | 51,803 | 49.9 K to 51.8 K (+3.83 %) |
| Jun 18 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Grant | A | 0.00 | 1,910 | 0 | 173,001 | 171.1 K to 173 K (+1.12 %) |
| Jun 17 2019 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Option Exercise | M | 31.12 | 10,550 | 328,316 | 0 | |
| Jun 17 2019 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Option Exercise | M | 31.12 | 25,000 | 778,000 | 10,550 | |
| Jun 17 2019 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Sell | S | 52.27 | 1,664 | 86,982 | 233,795 | 235.5 K to 233.8 K (-0.71 %) |
| Jun 17 2019 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Sell | S | 51.54 | 8,886 | 458,021 | 235,459 | 244.3 K to 235.5 K (-3.64 %) |
| Jun 17 2019 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Buy | M | 31.12 | 10,550 | 328,316 | 244,345 | 233.8 K to 244.3 K (+4.51 %) |
| Jun 17 2019 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Sell | S | 52.43 | 809 | 42,416 | 233,795 | 234.6 K to 233.8 K (-0.34 %) |
| Jun 17 2019 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Sell | S | 51.93 | 24,191 | 1,256,156 | 234,604 | 258.8 K to 234.6 K (-9.35 %) |
| Jun 17 2019 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Buy | M | 31.12 | 25,000 | 778,000 | 258,795 | 233.8 K to 258.8 K (+10.69 %) |
| Jun 13 2019 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Option Exercise | M | 31.12 | 9,887 | 307,683 | 35,550 | |
| Jun 13 2019 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Option Exercise | M | 30.84 | 15,113 | 466,085 | 0 | |
| Jun 13 2019 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Option Exercise | M | 31.12 | 4,563 | 142,001 | 45,437 | |
| Jun 13 2019 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Option Exercise | M | 30.84 | 20,437 | 630,277 | 15,113 | |
| Jun 13 2019 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Sell | S | 51.34 | 25,000 | 1,283,478 | 233,479 | 258.5 K to 233.5 K (-9.67 %) |
| Jun 13 2019 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Buy | M | 31.12 | 9,887 | 307,683 | 258,479 | 248.6 K to 258.5 K (+3.98 %) |
| Jun 13 2019 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Buy | M | 30.84 | 15,113 | 466,085 | 248,592 | 233.5 K to 248.6 K (+6.47 %) |
| Jun 13 2019 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Sell | S | 52.33 | 3,702 | 193,730 | 233,479 | 237.2 K to 233.5 K (-1.56 %) |
| Jun 13 2019 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Sell | S | 51.27 | 21,298 | 1,091,972 | 237,181 | 258.5 K to 237.2 K (-8.24 %) |
| Jun 13 2019 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Buy | M | 30.84 | 20,437 | 630,277 | 258,479 | 238 K to 258.5 K (+8.59 %) |
| Jun 13 2019 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Buy | M | 31.12 | 4,563 | 142,001 | 238,042 | 233.5 K to 238 K (+1.95 %) |
| Jun 13 2019 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | CFO | Option Exercise | M | 17.18 | 5,000 | 85,900 | 6,471 | |
| Jun 13 2019 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | CFO | Sell | S | 52.34 | 770 | 40,303 | 43,722 | 44.5 K to 43.7 K (-1.73 %) |
| Jun 13 2019 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | CFO | Sell | S | 51.30 | 4,230 | 216,979 | 44,492 | 48.7 K to 44.5 K (-8.68 %) |
| Jun 13 2019 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | CFO | Buy | M | 17.18 | 5,000 | 85,900 | 48,722 | 43.7 K to 48.7 K (+11.44 %) |
| Jun 10 2019 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Option Exercise | M | 31.12 | 1,500 | 46,680 | 10,897 | |
| Jun 10 2019 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Option Exercise | M | 31.12 | 3,000 | 93,360 | 12,397 | |
| Jun 10 2019 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Sell | S | 54.65 | 271 | 14,810 | 16,175 | 16.4 K to 16.2 K (-1.65 %) |
| Jun 10 2019 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Sell | S | 53.06 | 370 | 19,631 | 16,446 | 16.8 K to 16.4 K (-2.20 %) |
| Jun 10 2019 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Sell | S | 52.25 | 3,604 | 188,318 | 16,816 | 20.4 K to 16.8 K (-17.65 %) |
| Jun 10 2019 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Sell | S | 54.65 | 100 | 5,465 | 20,420 | 20.5 K to 20.4 K (-0.49 %) |
| Jun 10 2019 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Sell | S | 52.30 | 1,400 | 73,217 | 20,520 | 21.9 K to 20.5 K (-6.39 %) |
| Jun 10 2019 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Sell | S | 54.70 | 200 | 10,940 | 21,920 | 22.1 K to 21.9 K (-0.90 %) |
| Jun 10 2019 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Sell | S | 53.04 | 200 | 10,607 | 22,120 | 22.3 K to 22.1 K (-0.90 %) |
| Jun 10 2019 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Sell | S | 52.25 | 2,600 | 135,841 | 22,320 | 24.9 K to 22.3 K (-10.43 %) |
| Jun 10 2019 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Buy | M | 31.12 | 1,500 | 46,680 | 24,920 | 23.4 K to 24.9 K (+6.40 %) |
| Jun 10 2019 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Buy | M | 31.12 | 3,000 | 93,360 | 23,420 | 20.4 K to 23.4 K (+14.69 %) |
| May 15 2019 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | CFO | Option Exercise | M | 22.98 | 6,424 | 147,624 | 0 | |
| May 15 2019 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | CFO | Option Exercise | M | 17.18 | 5,000 | 85,900 | 11,471 | |
| May 15 2019 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | CFO | Sell | S | 57.36 | 4,674 | 268,103 | 43,722 | 48.4 K to 43.7 K (-9.66 %) |
| May 15 2019 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | CFO | Sell | S | 56.66 | 1,750 | 99,164 | 48,396 | 50.1 K to 48.4 K (-3.49 %) |
| May 15 2019 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | CFO | Buy | M | 22.98 | 6,424 | 147,624 | 50,146 | 43.7 K to 50.1 K (+14.69 %) |
| May 15 2019 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | CFO | Sell | S | 57.34 | 4,000 | 229,365 | 43,722 | 47.7 K to 43.7 K (-8.38 %) |
| May 15 2019 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | CFO | Sell | S | 56.52 | 1,000 | 56,520 | 47,722 | 48.7 K to 47.7 K (-2.05 %) |
| May 15 2019 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | CFO | Buy | M | 17.18 | 5,000 | 85,900 | 48,722 | 43.7 K to 48.7 K (+11.44 %) |
| May 10 2019 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Option Exercise | M | 31.12 | 1,500 | 46,680 | 15,397 | |
| May 10 2019 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Option Exercise | M | 31.12 | 3,000 | 93,360 | 16,897 | |
| May 10 2019 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Sell | S | 58.94 | 1,000 | 58,943 | 20,420 | 21.4 K to 20.4 K (-4.67 %) |
| May 10 2019 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Sell | S | 57.82 | 1,044 | 60,369 | 21,420 | 22.5 K to 21.4 K (-4.65 %) |
| May 10 2019 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Sell | S | 57.15 | 700 | 40,004 | 22,464 | 23.2 K to 22.5 K (-3.02 %) |
| May 10 2019 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Sell | S | 58.86 | 600 | 35,315 | 23,164 | 23.8 K to 23.2 K (-2.52 %) |
| May 10 2019 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Sell | S | 57.73 | 542 | 31,290 | 23,764 | 24.3 K to 23.8 K (-2.23 %) |
| May 10 2019 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Sell | S | 57.15 | 358 | 20,458 | 24,306 | 24.7 K to 24.3 K (-1.45 %) |
| May 10 2019 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Sell | S | 58.91 | 1,142 | 67,278 | 24,664 | 25.8 K to 24.7 K (-4.43 %) |
| May 10 2019 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Sell | S | 57.89 | 1,258 | 72,823 | 25,806 | 27.1 K to 25.8 K (-4.65 %) |
| May 10 2019 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Sell | S | 57.08 | 600 | 34,249 | 27,064 | 27.7 K to 27.1 K (-2.17 %) |
| May 10 2019 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Buy | M | 31.12 | 1,500 | 46,680 | 27,664 | 26.2 K to 27.7 K (+5.73 %) |
| May 10 2019 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Buy | M | 31.12 | 3,000 | 93,360 | 26,164 | 23.2 K to 26.2 K (+12.95 %) |
| May 10 2019 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Sell | S | 59.59 | 100 | 5,959 | 233,479 | 233.6 K to 233.5 K (-0.04 %) |
| May 10 2019 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Sell | S | 58.84 | 6,500 | 382,476 | 233,579 | 240.1 K to 233.6 K (-2.71 %) |
| May 10 2019 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Sell | S | 57.68 | 15,300 | 882,568 | 240,079 | 255.4 K to 240.1 K (-5.99 %) |
| May 10 2019 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Sell | S | 56.97 | 3,100 | 176,613 | 255,379 | 258.5 K to 255.4 K (-1.20 %) |